Jefferies Downgrades Athira Pharma (ATHA) to Hold

June 22, 2022 5:15 PM EDT
Get Alerts ATHA Hot Sheet
Price: $3.01 --0%

Rating Summary:
    2 Buy, 4 Hold, 0 Sell

Rating Trend: Down Down

Today's Overall Ratings:
    Up: 3 | Down: 3 | New: 12
Join SI Premium – FREE

Jefferies analyst Andrew Tsai downgraded Athira Pharma (NASDAQ: ATHA) from Buy to Hold with a price target of $3.00 (from $32.00).

For an analyst ratings summary and ratings history on Athira Pharma click here. For more ratings news on Athira Pharma click here.

Shares of Athira Pharma closed at $8.45 yesterday.

You May Also Be Interested In

Related Categories

Analyst PT Change, Downgrades